Showing results (101-110 of 171) with videos related to
Sort By:
Pageof 18
Genes, Chromosomes & Cancer|July 16, 2017
Clinical features and prognostic impact of PRDM16 expression in adult acute myeloid leukemiaGenki Yamato, Hiroki Yamaguchi, Hiroshi Handa, et al.International Journal of Hematology|March 13, 2012
RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study GroupHirozumi Sano, Akira Shimada, Tomohiko Taki, et al.Molecular and Cellular Biology|July 19, 2005
Infertility with defective spermiogenesis in mice lacking AF5q31, the target of chromosomal translocation in human infant leukemiaAtsushi Urano, Masaki Endoh, Tadashi Wada, et al.Blood Advances|May 1, 2024
Cytokine profiling in 128 patients with transient abnormal myelopoiesis: a report from the JPLSG TAM-10 trialGenki Yamato, Yusuke Tsumura, Hideki Muramatsu, et al.Plos One|January 19, 2021
Association of high-risk neuroblastoma classification based on expression profiles with differentiation and metabolismShunsuke Kimura, Masahiro Sekiguchi, Kentaro Watanabe, et al.Genes, Chromosomes & Cancer|January 31, 2003
Breakpoints at 1p36.3 in three MDS/AML(M4) patients with t(1;3)(p36;q21) occur in the first intron and in the 5' region of MEL1Phan Thi Xinh, Nguyen Khanh Tri, Hiromasa Nagao, et al.British Journal of Haematology|December 2, 2011
Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children's Cancer Study Group Study L99-15Takeshi Inukai, Nobutaka Kiyokawa, Dario Campana, et al.Genes, Chromosomes & Cancer|August 31, 2004
Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16)Yanming Zhang, Nancy Zeleznik-Le, Neelmini Emmanuel, et al.Blood|February 27, 2013
Naturally occurring oncogenic GATA1 mutants with internal deletions in transient abnormal myelopoiesis in Down syndromeTsutomu Toki, Rika Kanezaki, Eri Kobayashi, et al.Cancer Research|October 19, 2007
Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agentsYoshiyuki Furuichi, Kumiko Goi, Takeshi Inukai, et al.Pageof 18